PIAZZA, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 7.387
AS - Asia 5.136
EU - Europa 4.698
SA - Sud America 697
AF - Africa 71
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.031
Nazione #
US - Stati Uniti d'America 7.159
SG - Singapore 1.471
IT - Italia 1.167
CN - Cina 1.164
VN - Vietnam 1.128
HK - Hong Kong 737
RU - Federazione Russa 622
DE - Germania 600
BR - Brasile 538
SE - Svezia 516
IE - Irlanda 372
GB - Regno Unito 323
UA - Ucraina 258
CA - Canada 174
JP - Giappone 150
FR - Francia 143
FI - Finlandia 141
AT - Austria 114
NL - Olanda 112
IN - India 95
KR - Corea 82
ES - Italia 79
AR - Argentina 70
TR - Turchia 68
ID - Indonesia 49
PL - Polonia 49
BE - Belgio 40
DK - Danimarca 40
CH - Svizzera 38
MX - Messico 37
AU - Australia 32
ZA - Sudafrica 31
TW - Taiwan 30
CL - Cile 29
IR - Iran 29
BD - Bangladesh 26
EC - Ecuador 24
GR - Grecia 18
IQ - Iraq 17
PT - Portogallo 14
OM - Oman 10
TH - Thailandia 10
LT - Lituania 9
NO - Norvegia 9
VE - Venezuela 9
PH - Filippine 8
PY - Paraguay 8
SA - Arabia Saudita 8
CO - Colombia 7
KE - Kenya 7
MY - Malesia 7
UZ - Uzbekistan 7
JO - Giordania 6
PK - Pakistan 6
SI - Slovenia 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
EU - Europa 5
LB - Libano 5
MA - Marocco 5
PE - Perù 5
TN - Tunisia 5
UY - Uruguay 5
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
AL - Albania 3
CR - Costa Rica 3
KZ - Kazakistan 3
MD - Moldavia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
RE - Reunion 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LY - Libia 2
PA - Panama 2
RS - Serbia 2
SC - Seychelles 2
CI - Costa d'Avorio 1
GH - Ghana 1
HR - Croazia 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 18.027
Città #
Ann Arbor 1.468
Singapore 935
Hong Kong 725
Ashburn 560
Woodbridge 490
Milan 485
Houston 361
Dublin 350
Ho Chi Minh City 345
Chandler 309
Frankfurt am Main 308
Jacksonville 298
Hanoi 287
Wilmington 271
Fairfield 228
Santa Clara 228
Dearborn 205
New York 200
Beijing 149
Princeton 144
Hefei 143
Dallas 140
Los Angeles 138
Seattle 119
Nanjing 115
Vienna 99
Cambridge 90
Munich 89
São Paulo 67
Buffalo 66
Shanghai 65
Chicago 64
Moscow 64
The Dalles 61
Seoul 60
Helsinki 57
Lachine 55
Guangzhou 46
Tokyo 43
Jakarta 41
Lawrence 38
London 38
Boardman 37
Dong Ket 37
Rome 35
Da Nang 34
Nanchang 33
Warsaw 33
Council Bluffs 32
Altamura 31
Boydton 27
Ha Long 27
Haiphong 26
Rio de Janeiro 26
Toronto 26
Brussels 25
Denver 25
Montreal 24
Paris 24
Andover 23
Hiroshima 23
Shenyang 23
Bologna 22
Jinan 22
San Diego 22
Santiago 22
Boston 21
Falls Church 21
Hải Dương 21
Kent 21
Nuremberg 21
Ottawa 21
Quận Bình Thạnh 21
Bari 20
Biên Hòa 19
Brooklyn 19
Changsha 19
Lambeth 19
Amsterdam 18
Can Tho 18
Hebei 18
Tianjin 18
Florence 17
Ninh Bình 17
Atlanta 16
Hangzhou 16
Madrid 16
Naples 16
Bắc Ninh 15
Norwalk 15
Orem 15
Barcelona 14
Hyderabad 14
Vũng Tàu 14
Zhengzhou 14
Ankara 13
Ningbo 13
Poplar 13
San Francisco 13
Stockholm 13
Totale 11.282
Nome #
Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization 839
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers? 658
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 489
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 454
Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation 445
Feasibility of a standard cognitive assessment in European academic memory clinics 436
Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy 427
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 384
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 372
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 367
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 367
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 316
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 309
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 288
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 286
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 259
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 249
Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature 249
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 246
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 244
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 235
Ricerca quantitativa di Epstein-barr virus in campioni di liquor e sangue da pazienti affetti da sclerosi multipla 233
Cerebral Amyloid Angiopathy-Related Inflammation 230
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 228
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 226
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency 214
Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation 212
A challenging diagnosis of reversible “vascular” dementia: Cerebral amyloid angiopathy-related inflammation 211
Biological markers of vascular damage in Alzheimer’s disease patients 211
Anti-Aβ autoantibodies in CAA-ri vs AD patients: different singers for the same ARIA? 210
Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology 209
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 209
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 206
Ubiquitin regulates GGA3-mediated degradation of BACE1 200
Pathogenetic role of anti-AB autoantibodies in Cerebral Amyloid Angiopathy-related inflammation and Alzheimer's disease 197
Abrupt withdrawal of immunosuppressive drugs: a potential trigger for CAA-ri 192
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 188
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 186
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy 184
Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review 179
CSF biomarkers for Amyloid Related Imaging Abnormalities (ARIA) in immunotherapy trials of Alzheimer’s disease and Cerebral Amyloid Angiopathy: report from the iCAß International Network 175
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 172
Anti-abeta antibodies in CSF: markers for therapies? 172
The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications 170
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 170
Metodo e kit per la rilevazione di anticorpi 168
Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease 166
BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus. 162
Increased levels of tissue factor pathway inhibitor in cerebrospinal fluid are related to neurodegeneration in alzheimer’s disease patients 160
Pathogenetic similarities shared by Alzheimer's disease and multiple sclerosis 158
Iatrogenic CAA-ri supported by ARIA-E, raised CSF anti-Aβ autoantibodies and sTREM2 after COVID-19 vaccination 156
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 152
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 152
Platelets might mediate the increase of plasma glutamate in acute ischemic stroke: Relevance for early neurological deterioration 150
Autologous anti-Aß antibodies in caa-ri: new biomarker for detection of Amyloid-Related Imaging Abnormalities (ARIA) during Aß-disease modifying therapies for AD 149
CSF anti-Aß autoantibodies as novel biomarker for Cerebral Amyloid Angiopathy-related inflammation: implications for amyloid-related imaging abnormalities (ARIA) during passive immunization in Alzheimer’s disease 149
Author Response: Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 146
Effect of TNF-alpha on platelet glutamate uptake in Stroke patients 143
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study 141
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 138
A method and a kit for the detection of anti-beta amyloid antibodies 138
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 137
Biomarkers in cerebral amyloid angiopathy-related inflammation 136
Hemostasis components in cerebral amyloid angiopathy and Alzheimer’s disease 135
Symposium Immunotherapy Trials in CAA and AD: The ARIA paradox in AD and CAA: merely an adverse event or an out of tune proof of immunotherapy effectiveness? 131
Inflammatory CAA and AD Biomarkers International Network 130
Cerebrospinal Fluid Anti-Amyloid-Beta; Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation 129
Non-vascular leucoencephalic dementia: The case of Cerebral Amyloid Angiopathy related inflammation 129
CAA-ri and ARIA: Two Faces of the Same Coin? 125
Neurovascular Manifestations of Iron-Deficient Anemia: Narrative Review and Practical Reflections through a Teaching Case 125
Pathogenetic Role of Anti- Aß Autoantibodies in CAA-related Inflammation: Implications for Amyloid-modifying Therapies in AD 125
Natural amyloid-beta oligomers acutely impair the formation of a contextual fear memory in mice 124
Cerebral amyloid angiopathy-related inflammation. report of a case 123
Vascular damage and neurodegeneration 123
Anti-Aß autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease βiomarkers Collaborative Network (iCAβ) 122
Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy? 116
In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model 116
The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue 115
Auto-antibodies to Aß in CSF 110
Large Collaborative Registries and Real-World Data to Manage Amyloid-Related Imaging Abnormalities 107
Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA) 106
Why does ARIA‐E appear bright? A quantitative model linking brain tissue composition and T2 FLAIR hyperintensities 105
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease 104
Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease 103
Données récentes sur l’Amyloïdose Cérébrale Inflammatoire. 102
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 101
Anti-Amyloid Treatments: A Therapeutic Revolution, Ready for Europe 93
Anti-Aß autoantibodies and endothelial damage during spontaneous Amyloid-Related Imaging Abnormalities (ARIA): report from the inflammatory cerebral amyloid angiopathy and alzheimer's disease biomarkers collaborative network (iCAB) 89
The inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease Biomarkers International Network (iCAβ) initiative 84
Analytical Validation of a pre-Industrial Prototype Assay for Anti-Aβ Autoantibody ultrasensitive quantification in patients with CAA-ri and ARIA-E of Alzheimer’s disease Immunotherapy 83
Inflammatory CAA mechanisms and biomarkers– lessons for sporadic CAA diagnosis and treatment 82
Abstract W MP89: Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 81
Monoclonal antibodies for early Alzheimer disease: a long road to discovery and marketing approval, a short timeline for health systems to organise services 56
Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies 51
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 48
Microbiota-gut-brain axis dysregulation in Alzheimer’s disease and its modulation through probiotic supplementation 34
Mass Spectrometry Imaging in the clinical setting: do pretty images hold diagnostic potential? 33
Totale 18.844
Categoria #
all - tutte 56.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021762 0 0 0 0 0 80 120 82 126 135 78 141
2021/20221.039 96 86 114 97 74 106 33 31 42 76 74 210
2022/20231.727 204 419 146 146 147 232 96 91 172 16 37 21
2023/20241.316 44 67 59 62 180 274 229 82 133 32 39 115
2024/20253.696 164 421 317 135 297 179 277 202 382 463 291 568
2025/20265.665 1.434 862 773 1.142 1.232 222 0 0 0 0 0 0
Totale 18.844